Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
|
|
Surrozen, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/10/2023 |
8-K
| Quarterly results|
Docs:
|
"SURROZEN, INC. Condensed Consolidated Statements of Operations Three Months Ended March 31, 2023 2022 Operating expenses: Research and development $ 8,086 $ 9,371 General and administrative 5,299 5,122 Restructuring 1,207 — Total operating expenses 14,592 14,493 Loss from operations Interest income 547 49 Other income , net 6,497 Net loss $ $ Net loss per share attributable to common stockholders, basic and diluted $ $ Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 29,971 34,863 SURROZEN, INC. Condensed Consolidated Balance Sheets March 31, December 31, 2023 2022 Assets Current assets: Cash and cash equivalents $ 27,809 $ 24,690 Accounts receivable 1,978 1,978 Short-term marketable securities 33,937 51,148 Prepaid expen..." |
|
| 04/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/23/2023 |
8-K
| Other Events Interactive Data |
| 03/22/2023 |
8-K
| Quarterly results|
Docs:
|
"SURROZEN, INC. Consolidated Statements of Operations and Comprehensive Loss Year Ended December 31, 2022 2021 Collaboration and license revenue $ 12,500 $ — Operating expenses: Research and development 37,013 40,177 General and administrative 19,826 14,214 Total operating expenses 56,839 54,391 Loss from operations Interest income 781 72 Other income , net 7,554 Net loss $ $ Net loss per share attributable to common stockholders, basic and diluted $ $ Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 34,722 24,689 SURROZEN, INC. Consolidated Balance Sheets December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 24,690 $ 33,091 Accounts receivable 1,978 — Short-term marketable securities 51,148 68,760 Prepa..." |
|
| 01/05/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 12/15/2022 |
8-K
| Other Events Interactive Data |
| 10/06/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
8-K
| Quarterly results |
| 06/14/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 03/24/2022 |
8-K
| Quarterly results|
Docs:
|
"Surrozen, Inc. Consolidated Statements of Operations Year Ended December 31, 2021 2020 Operating expenses: Research and development $ 40,177 $ 25,684 General and administrative 14,214 7,123 Total operating expenses 54,391 32,807 Loss from operations Interest income 72 91 Other expense, net — Net loss $ $ Net loss per share attributable to common stockholders, basic and diluted $ $ Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 24,689,339 15,972,348 Surrozen, Inc. Consolidated Balance Sheet Data December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 33,091 $ 34,982 Short-term marketable securities 68,760 14,200 Prepaid expenses and other current assets 3,338 1,042 Total current assets 105,189 50,224 Pro..." |
|
| 02/24/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"PURCHASE AGREEMENT THIS PURCHASE AGREEMENT , dated as of February 18, 2022, is made by and between SURROZEN, INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof. WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company may, in its sole discretion, sell to the Investor, and the Investor may buy from the Company, up to Fifty Million Dollars of the Company’s common stock, $0.0001 par value per share . The shares of Common Stock to be purchased hereunder are referred to herein as the “Purchase Shares.” NOW THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good...",
"REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT , dated as of February 18, 2022, is made by and between SURROZEN, INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof . WHEREAS: The Company has agreed, upon the terms and subject to the conditions of the Purchase Agreement, to sell and issue to the Buyer up to Fifty Million Dollars of the Company’s common stock, par value $0.0001 per share , pursuant to the Purchase Agreement and issue to the Investor such number of shares of Common Stock as is required pursuant to the Purchase..." |
|
| 01/10/2022 |
8-K
| Other Events Interactive Data |
| 11/15/2021 |
8-K
| Quarterly results|
Docs:
|
"Surrozen, Inc. Condensed Consolidated Statements of Operations Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Operating expenses: Research and development $ 10,418 $ 6,958 $ 29,284 $ 17,034 General and administrative 3,287 1,683 10,112 4,937 Total operating expenses 13,705 8,641 39,396 21,971 Loss from operations Interest income 14 6 30 82 Other expense, net — — Net loss Net loss per share attributable to common stockholders, basic and diluted $ $ $ $ Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 27,401,956 18,507,423 21,291,480 15,261,552 Surrozen, Inc. Condensed Consolidated Balance Sheet Data Assets Current assets: Cash and cash equivalents $ 61,096 $ 34,982 Prepaid expenses..." |
|
| 08/17/2021 |
8-K
| Director compensation was amended/approved|
Docs:
|
"Certificate of Incorporation of Surrozen, Inc",
"Bylaws of Surrozen, Inc",
"Certificate of Corporate Domestication of Consonance-HFW Acquisition Corp",
"Investor Rights Agreement, by and among Surrozen, Inc., Consonance Life Sciences, and certain other investors",
"SURROZEN, INC. 2021 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: AUGUST 14, 2021 APPROVED BY THE STOCKHOLDERS: AUGUST 10, 2021 1. GENERAL. Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards. Available Awards. The Plan provides for the grant of the following Awards: Incentive Stock Options; Nonstatutory Stock Options; SARs; Restricted Stock Awards; RSU Awards; Performance Awards; and Other Awards. Adoption Date; Effective Date. The Pl...",
"SURROZEN, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: AUGUST 14, 2021 APPROVED BY THE STOCKHOLDERS: AUGUST 10, 2021 1. GENERAL; PURPOSE. The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible Employees that do not meet the requirements of an Employee Stock Purchase Plan. The Plan includes two components: a 423 Component and a Non-423 Component. The Company intends the 423 Component to qualify as an Employee Stock Purchase Plan. The provi...",
"Form of Indemnification Agreement",
"Securities and Exchange Commission 100 F Street, N.E.",
"List of Subsidiaries",
"Unaudited Condensed Interim Financial Statements and Related Notes of Legacy Surrozen, Inc. as of June 30, 2021 and 2020" |
|
| 08/12/2021 |
8-K
| Quarterly results |
| 08/10/2021 |
8-K
| Quarterly results |
| 08/02/2021 |
8-K
| Other Events |
| 07/30/2021 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...|
Docs:
|
"FORM 8-K",
"New Surrozen to Trade on Nasdaq as “SRZN” PRINCETON, N.J. - July 30, 2021 - Consonance-HFW Acquisition Corp. today announced that, upon the Domestication and the consummation of its pending business combination with Surrozen, Inc. , New Surrozen Common Stock and New Surrozen Warrants will be listed on The Nasdaq Global Select Market . Prior to the consummation of the Business Combination, CHFW will domesticate as a Delaware corporation and will change its name to “Surrozen, Inc.” . References to “New Surrozen” in this release refer to CHFW following the name change. In connection with the Domestication, each of the then issued and outstanding CHFW Class A ordinary shares, par value $0.0001 per share , and each issued and outstanding CHFW Class B ordinary share, par value $0.0001 per share..." |
|
| 05/14/2021 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Other Events |
| 04/15/2021 |
8-K
| Director compensation was amended/approved|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 15, 2021 Consonance-HFW Acquisition Corp. Cayman Islands 001-39635 98-15556622 1 Palmer Square, Suite 305 Princeton, NJ 08540 921-2333 Registrant's telephone number, including area code Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ...",
"BUSINESS COMBINATION AGREEMENT BY AND AMONG CONSONANCE-HFW ACQUISITION CORP., PERSEVERANCE MERGER SUB INC., AND, SURROZEN, INC. DATED AS OF APRIL 15, 2021",
"Sponsor Letter Agreement, by and among Consonance-HFW Acquisition Corp., Consonance Life Sciences, Donald J. Santel, Christopher Haqq, Jennifer Jarrett and Surrozen, Inc.",
"Form of Subscription Agreement",
"Form of Surrozen Transaction Support Agreement",
"Form of CHFW Transaction Support Agreement",
"Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration",
"Investor Presentation",
"Investor Script",
"Surrozen Business and Risk Factor Disclosures" |
|
| 01/07/2021 |
8-K
| Quarterly results |
| 11/30/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/25/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Underwriting Agreement, by and among the Company and J.P. Morgan Securities LLC as representative of the underwriters",
"Warrant Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Registration and Shareholder Rights Agreement, by and among the Company, the Sponsor and the Holders signatory thereto",
"Private Placement Units Purchase Agreement, between the Company and the Sponsor",
"Administrative Services Agreement, between the Company and the Sponsor",
"Letter Agreement, by and among the Company, the Sponsor and each director and officer of the Company",
"Press Release issued by the Company on November 18, 2020" |
|
|
|